Dipyridamole selectively inhibits inflammatory gene expression in platelet-monocyte aggregates - Wikidata - awgldk - TriplyDB

Dipyridamole selectively inhibits inflammatory gene expression in platelet-monocyte aggregates

Dipyridamole selectively inhibits inflammatory gene expression in platelet-monocyte aggregates

http://www.wikidata.org/entity/Q28213662

about

sameAs

Platelets in Pulmonary Immune Responses and Inflammatory Lung Diseases Anti-platelet therapy: phosphodiesterase inhibitors.Antiplatelet drugs Children undergoing cardiac surgery for complex cardiac defects show imbalance between pro- and anti-thrombotic activity Clinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic disease Platelet proteome reveals novel pathways of platelet activation and platelet-mediated immunoregulation in dengue Computational drug repositioning for peripheral arterial disease: prediction of anti-inflammatory and pro-angiogenic therapeutics.The neuron-astrocyte-microglia triad in a rat model of chronic cerebral hypoperfusion: protective effect of dipyridamole.CCN1/CYR61-mediated meticulous patrolling by Ly6Clow monocytes fuels vascular inflammation PDE8 regulates rapid Teff cell adhesion and proliferation independent of ICER.Time for Integrating Clinical, Lifestyle and Molecular Data to Predict Drug Responses.Platelet activation and apoptosis modulate monocyte inflammatory responses in dengue.Synthesis and dephosphorylation of MARCKS in the late stages of megakaryocyte maturation drive proplatelet formation.Novel anti-bacterial activities of β-defensin 1 in human platelets: suppression of pathogen growth and signaling of neutrophil extracellular trap formation.Preventing recurrent cerebrovascular events in patients with stroke or transient ischemic attack: the current data.Integrin αDβ2 (CD11d/CD18) is expressed by human circulating and tissue myeloid leukocytes and mediates inflammatory signaling.Expression of COX-2 in platelet-monocyte interactions occurs via combinatorial regulation involving adhesion and cytokine signaling Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum Platelet-monocyte aggregate formation and mortality risk in older patients with severe sepsis and septic shock Platelet-leukocyte interactions link inflammatory and thromboembolic events in ischemic stroke.Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Monocyte chemotactic protein-1 as a potential biomarker for early anti-thrombotic therapy after ischemic stroke.A review of the role of anticoagulation in the treatment of peripheral arterial disease.Targeting phosphodiesterases in anti-platelet therapy Signal-dependent protein synthesis by activated platelets: new pathways to altered phenotype and function.Translational therapeutics of dipyridamole.Reduction of microglial activity in a model of multiple sclerosis by dipyridamole.Platelets as cellular effectors of inflammation in vascular diseases.Selective amplification of glucocorticoid anti-inflammatory activity through synergistic multi-target action of a combination drug Platelets influence vascularized organ transplants from start to finish Multifunctional actions of approved and candidate stroke drugs.Alterations in platelet function during aging: clinical correlations with thromboinflammatory disease in older adults.The role of the blood transcriptome in innate inflammation and stroke.Platelets as central mediators of systemic inflammatory responses.Pharmacodynamic properties of antiplatelet agents: current knowledge and future perspectives.Amelioration of inflammation and cytotoxicity by dipyridamole in brain endothelial cells Dipyridamole prevents triple-negative breast-cancer progression.Recombinant amphiphilic protein micelles for drug delivery.Inhibiting the calcineurin-NFAT (nuclear factor of activated T cells) signaling pathway with a regulator of calcineurin-derived peptide without affecting general calcineurin phosphatase activity.Nucleoside transport inhibitor, dipyridamole, induced myocardial protection following hemorrhagic shock in ex vivo perfused rat hearts.

P2860

Q26739670-8299C320-B83C-474C-8387-DE8F16ECA724 Q27687228-196FD94C-B16A-4987-BFB7-C72E4778A329 Q28194430-D294E2B3-AA45-4314-945E-683BB7DB2727 Q28211087-4BF241EE-3E81-42A2-A171-C141B9F4E8E6 Q28218124-C6A28C38-7471-4601-BF5D-82DB03256726 Q30250939-C8E8C493-310C-4ADE-9C1B-2D03BB3E0299 Q30278668-875F88E0-6F73-4C64-BE43-6F407F93E728 Q30602337-06B7383C-5219-4645-80A0-BE511363A0FE Q30803044-7F29C187-50CB-4CBF-90F7-2F614AB62F5B Q30987183-44E35DBE-D6BF-4788-A78F-C1D4325A0AB6 Q31109183-231AB4D0-DD06-4818-8A23-53A74641AC1E Q33416386-CE8BBE97-565D-4B0E-83DA-EA503251BB16 Q33429010-36A112C9-802C-443C-A4EA-AA4F43ECF743 Q34079154-5B45B5BA-B91F-4401-A276-51FA4E57DEFA Q34092629-732C63A8-6836-4544-ADC9-2F7E6515E172 Q34557811-4363F847-14FE-4F75-839F-18F0C5EC4B7E Q35039893-9A354741-2F8D-4B29-AC66-FAC3C9430878 Q35101184-8F4223FA-10E9-4B17-B0DF-105EA8A1FEFC Q35197349-37283572-8AB6-4CC0-BE9C-F727F8E4C416 Q35633718-0536BE1D-F7E7-4ACD-A192-1F5E908D712B Q35752619-3E19E764-C915-4089-A68F-2F4971483783 Q36197280-E99DB71C-C946-4B2E-AAB5-14F170CACFBA Q36627535-9EF9552C-756F-4C80-A872-2634CDC58D72 Q36929627-6971641D-139A-49D9-BA7B-A3B2F34C2541 Q36996283-33FF1557-504B-46EE-9717-CD8F24982235 Q37041703-CEB273B8-59C4-4048-A3B0-3DB722659C2D Q37048242-2118FE1A-8BE2-4B3D-85F7-29C4D69BF530 Q37081746-92C6E5B5-E664-4EA1-A7FA-415684D0DBC4 Q37207076-B77ABCB1-1DC2-4BB2-B437-733E1005B075 Q37344903-FF48C0F8-AAA6-46DB-AB3E-4FA7694AB7C1 Q37358654-FAD3C4EC-35D7-4BE5-AB17-AD1D406B5D05 Q37646857-B3988270-F9BA-4494-8D9C-F6AA6C93FFB5 Q37800988-5EA7609B-0F73-40C7-B133-3314AC8122EB Q37809184-8FC4F175-940E-4E26-A3C7-4FB3563BDBBA Q38018679-05A9FDE6-C0C2-49E7-A839-0E8492B065B6 Q39066002-F9BBB8BA-2B85-4813-850C-F180BF41D1E8 Q39320362-0A08577C-5C39-4F5B-B822-D4258A9C09AB Q39468785-CA29929F-4553-47D2-A65A-10DD1343D472 Q39887982-2F20F974-C1FA-4A41-AAB3-65CB16AC6BAF Q42047578-7731BA6D-53B9-4FD5-AFBE-23872D286324

P2860

Dipyridamole selectively inhibits inflammatory gene expression in platelet-monocyte aggregates

http://www.wikidata.org/entity/Q28213662

description

2005 nî lūn-bûn

@nan

2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Dipyridamole selectively inhib ...... n platelet-monocyte aggregates

@ast

Dipyridamole selectively inhib ...... n platelet-monocyte aggregates

@en

Dipyridamole selectively inhib ...... n platelet-monocyte aggregates

@nl

type

label

Dipyridamole selectively inhib ...... n platelet-monocyte aggregates

@ast

Dipyridamole selectively inhib ...... n platelet-monocyte aggregates

@en

Dipyridamole selectively inhib ...... n platelet-monocyte aggregates

@nl

prefLabel

Dipyridamole selectively inhib ...... n platelet-monocyte aggregates

@ast

Dipyridamole selectively inhib ...... n platelet-monocyte aggregates

@en

Dipyridamole selectively inhib ...... n platelet-monocyte aggregates

@nl

P1433

Q28213662-855D6032-165E-4D8F-AD04-C67437AACE25

P1476

Q28213662-AA44CB52-ACF2-48C4-84B7-A7D235EDB925

P2093

Q28213662-3693FA33-AD34-47D3-AF5B-B581868E0653

Q28213662-4EA4277F-DB5B-4C75-8D48-CA814E15E6B7

Q28213662-63D3D546-B5A6-4C60-8AB9-83DBBC4D0D03

Q28213662-739836D1-A6E1-46EB-A01A-568507DD406F

Q28213662-A2E6D11B-5D0F-435C-BE9E-DB49B20675D9

Q28213662-C948BC7E-EDD8-4ACC-BC40-5058DDECAE2D

Q28213662-CB539332-CD22-4CAF-AD71-FEE672F12362

Q28213662-D4046578-176F-4F7B-8447-FD16B7E6DAF8

Q28213662-D79D385F-7154-44AE-917E-782F5332FA1F

P304

Q28213662-86A0D71C-300E-4331-AE89-8CA18F4E0584

P31

Q28213662-354E8910-0CE4-4B94-9E7B-EF94AAD74C25

P3181

Q28213662-4C6C27D7-A176-4193-9D68-576EAF20BF8F

P356

Q28213662-AC2A1ADE-3944-4830-894E-99622C7F73F6

P407

Q28213662-F87E8141-6221-4134-997C-03F85D2CACD5

P433

Q28213662-77250E2C-5302-4C6D-8C89-F336984B0261

P478

Q28213662-DDD98FC5-BA48-4CFC-AC81-C29D4625C9E9

P577

Q28213662-3B68AD1A-87A9-4AC6-9265-10F0E649EAC7

P698

Q28213662-B1413190-5F43-493C-9D09-12307EA18CC1

P921

Q28213662-8238ED60-8586-4D3C-A9BF-80B0BCECCB55

P3181

P356

01.CIR.0000154607.90506.45

P1433

P1476

Dipyridamole selectively inhib ...... n platelet-monocyte aggregates

@en

P2093

Andrew S Weyrich

http://www.w3.org/2001/XMLSchema#string

Dan A Dixon

http://www.w3.org/2001/XMLSchema#string

Eliott D Spencer

http://www.w3.org/2001/XMLSchema#string

Gopal K Marathe

http://www.w3.org/2001/XMLSchema#string

Guy A Zimmerman

http://www.w3.org/2001/XMLSchema#string

Jennifer R Kuhlmann-Eyre

http://www.w3.org/2001/XMLSchema#string

Melvin M Denis

http://www.w3.org/2001/XMLSchema#string

Stephen M Prescott

http://www.w3.org/2001/XMLSchema#string

Tom M McIntyre

http://www.w3.org/2001/XMLSchema#string

P304

633-42

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

5043997

http://www.w3.org/2001/XMLSchema#string

P356

10.1161/01.CIR.0000154607.90506.45

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P577

2005-02-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15668340

http://www.w3.org/2001/XMLSchema#string

P921